» Articles » PMID: 32974372

COVID-19 Pandemic: Group Testing

Overview
Specialty General Medicine
Date 2020 Sep 25
PMID 32974372
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Group testing via hypergraph factorization applied to COVID-19.

Hong D, Dey R, Lin X, Cleary B, Dobriban E Nat Commun. 2022; 13(1):1837.

PMID: 35383149 PMC: 8983763. DOI: 10.1038/s41467-022-29389-z.

References
1.
Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung S, Hayashi K . Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis. 2020; 94:154-155. PMC: 7270890. DOI: 10.1016/j.ijid.2020.03.020. View

2.
Shental N, Levy S, Wuvshet V, Skorniakov S, Shalem B, Ottolenghi A . Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers. Sci Adv. 2020; 6(37). PMC: 7485993. DOI: 10.1126/sciadv.abc5961. View

3.
Ienca M, Vayena E . On the responsible use of digital data to tackle the COVID-19 pandemic. Nat Med. 2020; 26(4):463-464. PMC: 7100462. DOI: 10.1038/s41591-020-0832-5. View

4.
Hellewell J, Abbott S, Gimma A, Bosse N, Jarvis C, Russell T . Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020; 8(4):e488-e496. PMC: 7097845. DOI: 10.1016/S2214-109X(20)30074-7. View

5.
Andersen K, Rambaut A, Lipkin W, Holmes E, Garry R . The proximal origin of SARS-CoV-2. Nat Med. 2020; 26(4):450-452. PMC: 7095063. DOI: 10.1038/s41591-020-0820-9. View